Patents by Inventor Tsuneya Ikezu

Tsuneya Ikezu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic Acid Encoding a Brain Derived Tau Kinase Polypeptide and Methods of Use Thereof
    Publication number: 20140130192
    Abstract: The present invention provides materials and methods for treating Alzheimer's disease and other tau related neurodegenerative disorders. A tau kinase, Brain Derived Tau Kinase (BDTK) is provided. BDTK can cause hyperphosphorylation of tau protein, which leads to formation of neurofibrillary tangles, which are implicated in the degenerative symptoms of Alzheimer's and other neurodegenerative disorders. Methods of diagnosis and treatment based on the discovery of this novel tau kinase are also provided.
    Type: Application
    Filed: December 31, 2013
    Publication date: May 8, 2014
    Applicant: Unemed Corporation
    Inventor: Tsuneya Ikezu
  • Nucleic Acid Encoding A Brain Derived Tau Kinase Polypeptide and Methods of Use Thereof
    Publication number: 20100058489
    Abstract: The present invention provides materials and methods for treating Alzheimer's disease and other tau related neurodegenerative disorders. A tau kinase, Brain Derived Tau Kinase (BDTK) is provided. BDTK can cause hyperphosphorylation of tau protein, which leads to formation of neurofibrillary tangles, which are implicated in the degenerative symptoms of Alzheimer's and other neurodegenerative disorders. Methods of diagnosis and treatment based on the discovery of this novel tau kinase are also provided.
    Type: Application
    Filed: April 17, 2009
    Publication date: March 4, 2010
    Inventor: Tsuneya Ikezu
  • Nucleic acid encoding a Brain Derived Tau Kinase polypeptide and methods of use thereof
    Patent number: 7521230
    Abstract: The present invention provides materials and methods for treating Alzheimer's disease and other tau related neurodegenerative disorders. A tau kinase, Brain Derived Tau Kinase (BDTK) is provided. BDTK can cause hyperphosphorylation of tau protein, which leads to formation of neurofibrillary tangles, which are implicated in the degenerative symptoms of Alzheimer's and other neurodegenerative disorders. Methods of diagnosis and treatment based on the discovery of this novel tau kinase are also provided.
    Type: Grant
    Filed: October 16, 2002
    Date of Patent: April 21, 2009
    Assignee: Board of Regents of the University of Nebraska
    Inventor: Tsuneya Ikezu
  • Antibodies specific for NEBR1 and methods of use thereof
    Patent number: 7074554
    Abstract: Materials and methods are provided to inhibit HIV replication in targeted host cells.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: July 11, 2006
    Assignee: The Board of Regents of the University of Nebraska
    Inventors: Tsuneya Ikezu, Gary Leisman, Kimberly A. Carlson, Howard E. Gendelman
  • Methods and compositions for the treatment of human immunodeficiency virus infection
    Publication number: 20050130128
    Abstract: Materials and methods are provided to inhibit HIV replication in targeted host cells.
    Type: Application
    Filed: December 10, 2003
    Publication date: June 16, 2005
    Inventors: Tsuneya Ikezu, Gary Leisman, Kimberly Carlson, Howard Gendelman
  • Methods and compositions for the treatment of Alzheimer's disease and other neurodegenerative disorders
    Publication number: 20040076958
    Abstract: The present invention provides materials and methods for treating Alzheimer's disease and other tau related neurodegenerative disorders. A tau kinase, Brain Derived Tau Kinase (BDTK) is provided. BDTK can cause hyperphosphorylation of tau protein, which leads to formation of neurofibrillary tangles, which are implicated in the degenerative symptoms of Alzheimer's and other neurodegenerative disorders. Methods of diagnosis and treatment based on the discovery of this novel tau kinase are also provided.
    Type: Application
    Filed: October 16, 2002
    Publication date: April 22, 2004
    Inventor: Tsuneya Ikezu
  • Methods and compositions for the treatment of human immunodeficiency virus infection
    Patent number: 6689877
    Abstract: Materials and methods are provided to inhibit HIV replication in targeted host cells.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: February 10, 2004
    Assignee: The Board of Regents of the University of Nebraska
    Inventors: Tsuneya Ikezu, Gary Leisman, Kimberly A. Carlson, Howard E. Gendelman
  • Methods and compositions for the treatment of human immunodeficiency virus infection
    Publication number: 20020151510
    Abstract: Materials and methods are provided to inhibit HIV replication in targeted host cells.
    Type: Application
    Filed: April 6, 2001
    Publication date: October 17, 2002
    Inventors: Tsuneya Ikezu, Gary Leisman, Kimberly A. Carlson, Howard E. Gendelman